Keratoacanthoma: A tumor in search of a classification

International Journal of Dermatology

Volumn 46, Issue 7, 2007, Pages 671-678

  Karaa, Amel ^a,b   Khachemoune, Amor ^a,b  

^a UNIVERSITY OF NORTH CAROLINA AT CHARLOTTE   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2B INTERFERON; ANGIOTENSIN 1 RECEPTOR; BLEOMYCIN; CORTICOSTEROID; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLINE; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; FLUOROURACIL; IMIQUIMOD; INTERCELLULAR ADHESION MOLECULE 1; KI 67 ANTIGEN; LECTIN RECEPTOR; LIQUID NITROGEN; METHOTREXATE; MINERAL OIL; NONSTEROID ANTIINFLAMMATORY AGENT; ONCOSTATIN M; PROTEIN BAK; PROTEIN BCL 2; PROTEIN P16INK4A; PROTEIN P53; RETINOID; SOLASODINE; TAR; TELOMERASE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR SUPPRESSOR PROTEIN; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ARGON LASER; BONE MARROW DISEASE; CARBON DIOXIDE LASER; CHROMOSOME ABERRATION; CIGARETTE SMOKING; CLINICAL FEATURE; COMPARATIVE GENOMIC HYBRIDIZATION; COUGHING; CRYOSURGERY; CRYOTHERAPY; DESICCATION; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; EPIDEMIOLOGICAL DATA; FINGER AMPUTATION; GENETIC PREDISPOSITION; HISTOCHEMISTRY; HISTOPATHOLOGY; HUMAN; IMMUNE DEFICIENCY; INCIDENCE; KERATOACANTHOMA; LASER SURGERY; LIVER DYSFUNCTION; LUNG DISEASE; MALIGNANT TRANSFORMATION; MEDICAL DECISION MAKING; PANCYTOPENIA; PATHOGENESIS; RADIOTHERAPY; REVIEW; SKIN BIOPSY; SKIN DISEASE; SKIN SURGERY; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; ULTRAVIOLET RADIATION; UNITED STATES; WART VIRUS; YAG LASER;

DIAGNOSIS, DIFFERENTIAL; GENETIC PREDISPOSITION TO DISEASE; HUMANS; KERATOACANTHOMA; NEOPLASMS, SQUAMOUS CELL; SKIN NEOPLASMS; SYNDROME; ULTRAVIOLET RAYS;

EID: 34447271722     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03260.x     Document Type: Review

References (108)

1. Schwartz RA. Keratoacanthoma: A clinico-pathologic enigma. Dermatol Surg 2004; 30: 326-333.
2. Hutchinson JA. Morbid growths and tumours: The crateriform ulcer of the face, a form of acute epithelial cancer. Trans Pathol Soc Lond 1889; 40: 275-281.
3. Musso L. Spontaneous resolution of a molluscum sebaceum. Proc R Soc Med 1950; 43: 838-839.
4. Halnan KE. Molluscum pseudocarcinomatosum. Lancet 1953; 265: 1358.
5. Rulon DB, Helwig EB. Cutaneous sebaceous neoplasms. Cancer 1974; 33: 82-102.
6. Brown JB, Fryer MP. Fallacy of term self-healing epidermoid carcinoma and limitations of microscopic interpretations. Surg Gynecol Obstet 1955; 100: 179-183.
7. Rudolph R, Gray AP, Leipold HW. Intracutaneous cornifying epithelioma ("keratoacanthoma") of dogs and keratoacanthoma of man. Cornell Vet 1977; 67: 254-264.
8. Grinspan D, Abulafia J. Idiopathic cutaneous pseudoepitheliomatous hyperplasia, verrugoma (Gougerot), molluscum sebaceum (MacCormac and Scarff), self-healing, primary, squamous-cell epithelioma (Ferguson Smith), and keratoacanthoma (Rook and Whimster). Cancer 1955; 8: 1047-1056.
9. Miedzinski F, Kozakiewicz J. Keratoacanthoma centrifugum - a special variety of keratoacanthoma. Hautarzt 1962; 13: 348-352.
10. Kwittken J. A histologic chronology of the clinical course of the keratocarcinoma (so-called keratoacanthoma). Mt Sinai J Med 1975; 42: 127-135.
11. Buescher L, DeSpain JD, Diaz-Arias AA, et al. Keratoacanthoma arising in an organoid nevus during childhood: Case report and literature review. Pediatr Dermatol 1991; 8: 117-119.
12. Hodak E, Jones RE, Ackerman AB. Solitary keratoacanthoma is a squamous-cell carcinoma: Three examples with metastases. Am J Dermatopathol 1993; 15: 332-342.
13. Maruani A, Michenet P, Lagasse JP, et al. [Keratoacanthoma of the anal margin]. Gastroenterol Clin Biol 2004; 28: 906-908.
14. Perdigao FB, Pierre-Filho Pde T, Natalino RJ, et al. Conjunctival keratoacanthoma. Rev Hosp Clin Fac Med Sao Paulo 2004; 59: 135-137.
15. Miot HA, Miot LD, da Costa AL, et al. Association between solitary keratoacanthoma and cigarette smoking: A case-control study. Dermatol Online J 2006; 12: 2.
16. Reizner GT, Chuang TY, Elpern DJ, et al. Keratoacanthoma in Japanese Hawaiians in Kauai, Hawaii. Int J Dermatol 1995; 34: 851-853.
17. Sullivan JJ. Keratoacanthoma: The Australian experience. Australas J Dermatol 1997; 38: S36-S39.
18. Dufresne RG, Marrero GM, Robinson-Bostom L. Seasonal presentation of keratoacanthomas in Rhode Island. Br J Dermatol 1997; 136: 227-229.
19. Ponti G, Ponz de Leon M. Muir-Torre syndrome. Lancet Oncol 2005; 6: 980-987.
20. Consigli JE, Gonzalez ME, Morsino R, et al. Generalized eruptive keratoacanthoma (Grzybowski variant). Br J Dermatol 2000; 142: 800-803.
21. Chowdhury RK, Padhi T, Das GS. Keratoacanthoma of the conjunctiva complicating xeroderma pigmentosum. Indian J Dermatol Venereol Leprol 2005; 71: 430-431.
22. Craddock KJ, Rao J, Lauzon GJ, et al. Multiple keratoacanthomas arising post-UVB therapy. J Cutan Med Surg 2004; 8: 239-243.
23. Talve L, Stenback F, Jansen CT. UVA irradiation increases the incidence of epithelial tumors in UVB-irradiated hairless mice. Photodermatol Photoimmunol Photomed 1990; 7: 109-115.
24. Chuang TY, Heinrich LA, Schultz MD, et al. PUVA and skin cancer. A historical cohort study on 492 patients. J Am Acad Dermatol 1992; 26: 173-177.
25. Letzel S, Drexler H. Occupationally related tumors in tar refinery workers. J Am Acad Dermatol 1998; 39: 712-720.
26. Heidenreich RK, Gongloff RK, Wescott WB. A solitary, exophytic, crateriform lesion on the mandibular retromolar gingiva. J Am Dent Assoc 1986; 112: 377-379.
27. Jarvholm B, Easton D. Models for skin tumour risks in workers exposed to mineral oils. Br J Cancer 1990; 62: 1039-1041.
28. Pattee SF, Silvis NG. Keratoacanthoma developing in sites of previous trauma: A report of two cases and review of the literature. J Am Acad Dermatol 2003; 48: S35-S38.
29. Epstein EH Jr, Epstein EH. Keratoacanthoma recurrent after surgical excision. J Dermatol Surg Oncol 1978; 4: 524-525.
30. Poleksic S, Yeung KY. Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: A mutagenic effect of polychemotherapy in a patient with Hodgkin's disease? Cancer 1978; 41: 12-16.
31. Goldberg LH, Silapunt S, Beyrau KK, et al. Keratoacanthoma as a postoperative complication of skin cancer excision. J Am Acad Dermatol 2004; 50: 753-758.
32. Batinac T, Zamolo G, Coklo M, et al. Expression of cell cycle and apoptosis regulatory proteins in keratoacanthoma and squamous cell carcinoma. Pathol Res Pract 2006; 202: 599-607.
33. Hu W, Cook T, Oh CW, et al. Expression of the cyclin-dependent kinase inhibitor p27 in keratoacanthoma. J Am Acad Dermatol 2000; 42: 473-475.
34. Clausen OP, Beigi M, Bolund L, et al. Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization. J Invest Dermatol 2002; 119: 1367-1372.
35. Machin P, Catasus L, Pons C, et al. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome. J Cutan Pathol 2002; 29: 415-420.
36. Langenbach N, Kroiss MM, Ruschoff J, et al. Assessment of microsatellite instability and loss of heterozygosity in sporadic keratoacanthomas. Arch Dermatol Res 1999; 291: 1-5.
37. Forslund O, DeAngelis PM, Beigi M, et al. Identification of human papillomavirus in keratoacanthomas. J Cutan Pathol 2003; 30: 423-429.
38. Saftic M, Batinac T, Zamolo G, et al. HPV 6-positive giant keratoacanthoma in an immunocompetent patient. Tumori 2006; 92: 79-82.
39. Stockfleth E, Meinke B, Arndt R, et al. Identification of DNA sequences of both genital and cutaneous HPV types in a small number of keratoacanthomas of nonimmunosuppressed patients. Dermatology 1999; 198: 122-125.
40. Hsi ED, Svoboda-Newman SM, Stern RA, et al. Detection of human papillomavirus DNA in keratoacanthomas by polymerase chain reaction. Am J Dermatopathol 1997; 19: 10-15.
41. Euvrard S, Chardonnet Y, Pouteil-Noble C, et al. Association of skin malignancies with various and multiple carcinogenic and noncarcinogenic human papillomaviruses in renal transplant recipients. Cancer 1993; 72: 2198-2206.
42. Schwartz RA. Keratoacanthoma. J Am Acad Dermatol 1994; 30: 1-19.
43. Ghadially FN, Barton BW, Kerridge DF. The etiology of keratoacanthoma. Cancer 1963; 16: 603-611.
44. Attili S, Attili VR. Keratoacanthoma centrifugum marginatum arising in vitiligo: A case report. Dermatol Online J 2006; 12: 18.
45. Oh CK, Son HS, Lee JB, et al. Intralesional interferon alfa-2b treatment of keratoacanthomas. J Am Acad Dermatol 2004; 51: S177-S180.
46. Beham A, Regauer S, Soyer HP, et al. Keratoacanthoma: A clinically distinct variant of well differentiated squamous cell carcinoma. Adv Anat Pathol 1998; 5: 269-280.
47. Hundeiker M. Clinical variations of keratoacanthomas. Z Hautkr 1978; 53: 563-571.
48. Sanchez Yus E, Simon P, Requena L, et al. Solitary keratoacanthoma: A self-healing proliferation that frequently becomes malignant. Am J Dermatopathol 2000; 22: 305-310.
49. Griffiths RW. Keratoacanthoma observed. Br J Plast Surg 2004; 57: 485-501.
50. Seifert A, Nasemann T. Keratoacanthoma and its clinical variants. Review of the literature and histopathologic analysis of 90 cases. Hautarzt 1989; 40: 189-202.
51. Batinac T, Zamolo G, Coklo M, et al. Possible key role of granzyme B in keratoacanthoma regression. Med Hypotheses 2006; 66: 1129-1132.
52. Gottfarstein-Maruani A, Michenet P, Kerdraon R, et al. Keratoacanthoma: two cases with intravascular spread. Ann Pathol 2003; 23: 438-442.
53. Sinha A, Marsh R, Langtry J. Spontaneous regression of subungual keratoacanthoma with reossification of underlying distal lytic phalynx. Clin Exp Dermatol 2005; 30: 20-22.
54. Freedman PD, Kerpel SM, Begel H, et al. Solitary intraoral keratoacanthoma. Report of a case. Oral Surg Oral Med Oral Pathol 1979; 47: 74-76.
55. Janette A, Pecaro B, Lonergan M, et al. Solitary intraoral keratoacanthoma: Report of a case. J Oral Maxillofac Surg 1996; 54: 1026-1030.
56. Hofer SO, Jackson IT. Self-involution of giant keratoacanthoma on the tip of the nose. Plast Reconstr Surg 2004; 113: 765-766.
57. Moriyama M, Watanabe T, Sakamoto N, et al. A case of giant keratoacanthoma of the auricle. Auris Nasus Larynx 2000; 27: 185-188.
58. Webb AJ, Ghadially FN. Massive or giant keratoacanthoma. J Pathol Bacteriol 1966; 91: 505-509.
59. Leonard AL, Hanke CW. Treatment of giant keratoacanthoma with intralesional 5-fluorouracil. J Drugs Dermatol 2006; 5: 454-456.
60. Chen W, Koenig C. Vulvar keratoacanthoma: A report of two cases. Int J Gynecol Pathol 2004; 23: 284-286.
61. Sterry W, Steigleder GK, Pullmann H, et al. Eruptive keratoacanthoma. Hautarzt 1981; 32: 119-125.
62. Marshall J, Findlay GH. Multiple primary self-healing squamous epithelioma of the skin (Ferguson Smith), and its relationship to molluscum sebaceum. S Afr Med J 1953; 27: 1000-1005.
63. Ferguson-Smith J. Multiple primary, self-healing squamous epithelioma of the skin. Br J Dermatol 1948; 60: 315-318.
64. Agarwal M, Chander R, Karmakar S, et al. Multiple familial keratoacanthoma of Witten and Zak - a report of three siblings. Dermatology 1999; 198: 396-399.
65. Ponti G, Losi L, Di Gregorio C, et al. Identification of Muir-Torre syndrome among patients with sebaceous tumors and keratoacanthomas: Role of clinical features, microsatellite instability, and immunohistochemistry. Cancer 2005; 103: 1018-1025.
66. Wee SA. Multiple eruptive keratoacanthomas, de novo. Dermatol Online J 2004; 10: 19.
67. Bart RS, Kopf AW. Techniques of biopsy of cutaneous neoplasms. J Dermatol Surg Oncol 1979; 5: 979-987.
68. Cribier B, Asch P, Grosshans E. Differentiating squamous cell carcinoma from keratoacanthoma using histopathological criteria. Is it possible? A study of 296 cases. Dermatology 1999; 199: 208-212.
69. Ackerman AB. Squamous-cell carcinoma vs. keratoacanthoma. J Dermatol Surg Oncol 1982; 8: 418.
70. Melendez ND, Smoller BR, Morgan M. VCAM (CD-106) and ICAM (CD-54) adhesion molecules distinguish keratoacanthomas from cutaneous squamous cell carcinomas. Mod Pathol 2003; 16: 8-13.
71. Takeda H, Kondo S. Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression. Am J Pathol 2001; 158: 1633-1637.
72. Kerschmann RL, McCalmont TH, LeBoit PE. p53 oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch Dermatol 1994; 130: 181-186.
73. Cain CT, Niemann TH, Argenyi ZB. Keratoacanthoma versus squamous cell carcinoma. An immunohistochemical reappraisal of p53 protein and proliferating cell nuclear antigen expression in keratoacanthoma-like tumors. Am J Dermatopathol 1995; 17: 324-331.
74. Putti TC, Teh M, Lee YS. Biological behavior of keratoacanthoma and squamous cell carcinoma: Telomerase activity and COX-2 as potential markers. Mod Pathol 2004; 17: 468-475.
75. Skalova A, Michal M. Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinomas of the skin. Immunohistochemical study using the MIB 1 antibody in formalin-fixed paraffin sections. Am J Dermatopathol 1995; 17: 332-334.
76. Ho T, Horn T, Finzi E. Transforming growth factor alpha expression helps to distinguish keratoacanthomas from squamous cell carcinomas. Arch Dermatol 1991; 127: 1167-1171.
77. Kannon G, Park HK. Utility of peanut agglutinin (PNA) in the diagnosis of squamous cell carcinoma and keratoacanthoma. Am J Dermatopathol 1990; 12: 31-36.
78. Ariano MC, Wiley EL, Ariano L, et al. H, peanut lectin receptor, and carcinoembryonic antigen distribution in keratoacanthomas, squamous dysplasias, and carcinomas of skin. J Dermatol Surg Oncol 1985; 11: 1076-1083.
79. Kaabipour E, Haupt HM, Stern JB, et al. p16 expression in keratoacanthomas and squamous cell carcinomas of the skin: An immunohistochemical study. Arch Pathol Lab Med 2006; 130: 69-73.
80. Tran TA, Ross JS, Sheehan CE, et al. Comparison of oncostatin M expression in keratoacanthoma and squamous cell carcinoma. Mod Pathol 2000; 13: 427-432.
81. Mukunyadzi P, Sanderson RD, Fan CY, et al. The level of syndecan-1 expression is a distinguishing feature in behavior between keratoacanthoma and invasive cutaneous squamous cell carcinoma. Mod Pathol 2002; 15: 45-49.
82. Biesterfeld S, Josef J. Differential diagnosis of keratoacanthoma and squamous cell carcinoma of the epidermis by MIB-1 immunohistometry. Anticancer Res 2002; 22: 3019-3023.
83. Kuivanen TT, Jeskanen L, Kyllonen L, et al. Transformation-specific matrix metalloproteinases, MMP-7 and MMP-13, are present in epithelial cells of keratoacanthomas. Mod Pathol 2006; 19: 1203-1212.
84. Asch PH, Basset P, Roos M, et al. Expression of stromelysin 3 in keratoacanthoma and squamous cell carcinoma. Am J Dermatopathol 1999; 21: 146-150.
85. Slater M, Barden JA. Differentiating keratoacanthoma from squamous cell carcinoma by the use of apoptotic and cell adhesion markers. Histopathology 2005; 47: 170-178.
86. Clausen OP, Aass HC, Beigi M, et al. Are keratoacanthomas variants of squamous cell carcinomas?: A comparison of chromosomal aberrations by comparative genomic hybridization. J Invest Dermatol 2006; 126: 2308-2315.
87. Wiemers S, Stengel R, Schopf E, et al. Subungual keratoacanthoma. Hautarzt 1994; 45: 25-28.
88. Shriner DL, McCoy DK, Goldberg DJ, et al. Mohs micrographic surgery. J Am Acad Dermatol 1998; 39: 79-97.
89. Griffiths RW, Feeley K, Suvarna SK. Audit of clinical and histological prognostic factors in primary invasive squamous cell carcinoma of the skin: Assessment in a minimum 5 year follow-up study after conventional excisional surgery. Br J Plast Surg 2002; 55: 287-292.
90. Ansai S, Manabe M. Possible spontaneous regression of a metastatic lesion of keratoacanthoma-like squamous cell carcinoma in a regional lymph node. J Dermatol 2005; 32: 899-903.
91. Nedwich JA. Evaluation of curettage and electrodesiccation in treatment of keratoacanthoma. Australas J Dermatol 1991; 32: 137-141.
92. Caccialanza M, Sopelana N. Radiation therapy of keratoacanthomas: results in 55 patients. Int J Radiat Oncol Biol Phys 1989; 16: 475-477.
93. Neumann RA, Knobler RM. Argon laser treatment of small keratoacanthomas in difficult locations. Int J Dermatol 1990; 29: 733-736.
94. Thiele JJ, Ziemer M, Fuchs S, et al. Combined 5-fluorouracil and Er:YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg. Dermatol Surg 2004; 30: 1556-1560.
95. Georgieva VB, Ziangirova GG, Kasparov AA. Results of a multi-year use of combined laser-surgical treatment in tumors of the epibulbar and limbocorneal localizations. Vestn Oftalmol 2004; 120: 3-5.
96. Gray RJ, Meland NB. Topical 5-fluorouracil as primary therapy for keratoacanthoma. Ann Plast Surg 2000; 44: 82-85.
97. Sanders S, Busam KJ, Halpern AC, et al. Intralesional corticosteroid treatment of multiple eruptive keratoacanthomas: Case report and review of a controversial therapy. Dermatol Surg 2002; 28: 954-958.
98. Sayama S, Tagami H. Treatment of keratoacanthoma with intralesional bleomycin. Br J Dermatol 1983; 109: 449-452.
99. Andreassi A, Pianigiani E, Taddeucci P, et al. Guess what! Keratoacanthoma treated with intralesional bleomycin. Eur J Dermatol 1999; 9: 403-405.
100. Di Lernia V, Ricci C, Albertini G. Spontaneous regression of keratoacanthoma can be promoted by topical treatment with imiquimod cream. J Eur Acad Dermatol Venereol 2004; 18: 626-629.
101. Cohen PR, Schulze KE, Teller CF, et al. Intralesional methotrexate for keratoacanthoma of the nose. Skinmed 2005; 4: 393-395.
102. Cham BE, Daunter B, Evans RA. Topical treatment of malignant and premalignant skin lesions by very low concentrations of a standard mixture (BEC) of solasodine glycosides. Cancer Lett 1991; 59: 183-192.
103. McNairy DJ. Intradermal triamcinolone therapy of keratoacanthomas. Arch Dermatol 1964; 89: 136-140.
104. Levine N, Miller RC, Meyskens FL Jr. Oral isotretinoin therapy. Use in a patient with multiple cutaneous squamous cell carcinomas and keratoacanthomas. Arch Dermatol 1984; 120: 1215-1217.
105. Tarnowski WM. Multiple keratoacanthomata. Response of a case to systemic chemotherapy. Arch Dermatol 1966; 94: 74-80.
106. Oakley A, Ng S. Grzybowski's generalized eruptive keratoacanthoma: remission with cyclophosphamide. Australas J Dermatol 2005; 46: 118-123.
107. Grau MV, Baron JA, Langholz B, et al. Effect of NSAIDs on the recurrence of nonmelanoma skin cancer. Int J Cancer 2006; 119: 682-686.
108. Butler GJ, Neale R, Green AC, et al. Nonsteroidal anti-inflammatory drugs and the risk of actinic keratoses and squamous cell cancers of the skin. J Am Acad Dermatol 2005; 53: 966-972.